Central Veterinary Research Laboratory, Khartoum, Sudan.
Faculty of Veterinary Medicine, Sudan University for Science and Technology, Khartoum North, Sudan.
Transbound Emerg Dis. 2020 Mar;67 Suppl 1:26-34. doi: 10.1111/tbed.13374.
Tropical theileriosis constraints the development of the dairy industry in the Sudan and vaccination using live attenuated schizont vaccines is considered a promising measure for its control. The present study was carried out to investigate the ability of recombinant T. annulata surface protein (TaSP) to improve the efficacy of the attenuated Atbara cell line in protecting calves against field challenge. To this end, 23 cross-bred (Friesian × Kenana) calves were divided into four groups. Animals in group 1 (n = 5) were left unvaccinated. Group 2 (n = 6) received the Atbara cell line, animals in group 3 (n = 6) were immunized with three doses of TaSP on days 21, 49 and 77, while animals in group 4 (n = 6) received the cell line vaccine on day 0 and three doses of TaSP in Freund's incomplete adjuvant at days 21, 49 and 77. Twenty-eight days after the last TaSP boost, all groups were challenged by exposing them to natural field tick infestation in a region known to be endemic for tropical theileriosis. No thermal reactions, piroplasms or schizonts were observed in the immunized animals following immunization. Upon challenge, all animals showed a range of symptoms of clinical theileriosis with variable degrees of severity. The application of TaSP alone appeared to have no effect in terms of protection. The efficacy of the cell line alone was lower than the 100% level of protection against mortality observed in the group that received the combined cell line vaccine and TaSP, suggesting a synergistic effect of this combination.
热带泰勒虫病限制了苏丹奶业的发展,使用活减毒裂殖体疫苗接种被认为是控制该病的一种有前途的措施。本研究旨在调查重组 T. annulata 表面蛋白 (TaSP) 提高减毒 Atbara 细胞系在保护犊牛免受田间挑战中的功效的能力。为此,将 23 头杂交(弗里斯兰牛×肯纳纳牛)犊牛分为四组。第 1 组(n = 5)的动物未接种疫苗。第 2 组(n = 6)接种了 Atbara 细胞系,第 3 组(n = 6)的动物在第 21、49 和 77 天接受了三剂 TaSP 免疫,第 4 组(n = 6)在第 0 天接种了细胞系疫苗,并在第 21、49 和 77 天在弗氏不完全佐剂中接受了三剂 TaSP。在最后一次 TaSP 加强免疫后 28 天,所有组均通过在已知存在热带泰勒虫病流行的地区暴露于自然田间 tick 感染来进行挑战。免疫后,免疫动物未观察到热反应、巴贝斯虫或裂殖体。在挑战时,所有动物均表现出一系列临床泰勒虫病症状,严重程度不同。单独应用 TaSP 似乎没有保护作用。单独使用细胞系的功效低于接种联合细胞系疫苗和 TaSP 组观察到的 100%死亡率保护水平,表明这种组合具有协同作用。